Therapeutic Targeting of Long Non-Coding RNAs in Cancer

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Long non-coding RNAs (lncRNAs) are a substantial component of the human transcriptome.
• Their cell- and/or tissue/tumor-specific expression patterns make them attractive targets for therapeutic intervention.
• Dysregulation of lncRNAs is implicated in various cancer types.

Purpose of the Study:

• To review the diverse functions of lncRNAs in different cancer types.
• To discuss recent advancements in nucleic acid drug development, particularly oligonucleotide-based therapies.
• To highlight the potential of lncRNAs as therapeutic targets for cancer treatment.

Main Methods:

• Literature review of studies on lncRNA function in cancer.
• Analysis of recent developments in oligonucleotide therapeutics.
• Exploration of lncRNA-targeted strategies for cancer therapy.

Main Results:

• lncRNAs exhibit a wide range of functions across various cancers.
• Oligonucleotide-based therapies represent a promising strategy for inhibiting tumor progression.
• Specific lncRNAs can be targeted to modulate cancer development.

Conclusions:

• lncRNAs are versatile molecules with significant potential as cancer therapeutic targets.
• Nucleic acid therapeutics, especially oligonucleotide-based approaches, offer a novel avenue for cancer treatment.
• Targeting lncRNAs provides a viable strategy to combat diverse aspects of cancer progression.